Max India DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
1.04×1.04×1.01×1.13×5.91×
0.92×0.89×1.01×0.78×0.22×
−64.8%−68.7%−94.4%−36.8%−4.0%
0.29×0.29×0.22×0.24×0.25×
1.64×1.64×1.76×1.39×1.39×
−29.5%−30.4%−37.5%−10.7%−1.8%
−31.8%−31.8%−32.7%−10.9%−1.8%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

MAXIND₹150.26

Max India Limited

· Banking & Finance
₹ CrorePeersHEXATRADEXVLSFINANCEBLALJINDALPHOTAFSLJPOLYINVSTVHLSTELMcap ₹789 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×5.911.131.011.041.04
Interest Burden (Pretax/EBIT) ×0.220.781.010.890.92
EBIT Margin %-3.95-36.81-94.41-68.72-64.85
Asset Turnover ×0.250.240.220.290.29
Financial Leverage (Assets/Equity) ×1.391.391.761.641.64
ROE (5-step product, year-end total equity) %-1.80-10.71-37.45-30.39-29.48
ROE (owners' profit / average owners' equity) %-1.76-10.90-32.71-31.77-31.77
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.